Acute allergic reaction: Difference between revisions
No edit summary |
|||
| Line 14: | Line 14: | ||
==Management== | ==Management== | ||
#[[H1 agonist]]: [[diphenhydramine]] 50mg PO | |||
#[[H2 agonist]]: [[Ranitidine]] | |||
#*Improves urticaria but not angioedema at 2 hours<ref>Lin, RY et al. Improved Outcomes in Patients With Acute Allergic Syndromes Who Are Treated With Combined H1 and H2 Antagonists. Annals of Emergency Medicine. 36:5 NOVEMBER 2000.</ref> | |||
*[[Corticosteroids]] are of questionable efficacy | *[[Corticosteroids]] are of questionable efficacy | ||
*Rule out [[Anaphylaxis]] | *Rule out [[Anaphylaxis]] | ||
Revision as of 04:12, 21 October 2015
Background
- Similar to Anaphylaxis but does not meet all the requirements (i.e. just skin manifestations)
- Type I hypersensitivity reaction
Clinical Features
- Presentation can be delayed
Differential Diagnosis
Acute allergic reaction
- Allergic reaction/urticaria
- Anaphylaxis
- Angioedema
- Anxiety attack
- Asthma exacerbation
- Carcinoid syndrome
- Cold urticaria
- Contrast induced allergic reaction
- Scombroid
- Shock
- Transfusion reaction
Diagnosis
- Clinical
Management
- H1 agonist: diphenhydramine 50mg PO
- H2 agonist: Ranitidine
- Improves urticaria but not angioedema at 2 hours[1]
- Corticosteroids are of questionable efficacy
- Rule out Anaphylaxis
- Difficult to differentiate from Angioedema
Disposition
- Consider brief observation in the ED for improvement of symptoms
See Also
References
- ↑ Lin, RY et al. Improved Outcomes in Patients With Acute Allergic Syndromes Who Are Treated With Combined H1 and H2 Antagonists. Annals of Emergency Medicine. 36:5 NOVEMBER 2000.